The Beers Criteria: Potentially Inappropriate Medications for Seniors

The Beers Criteria: Potentially Inappropriate Medications for Seniors

Every year, millions of older adults in the U.S. take medications that could do more harm than good. It’s not because their doctors are careless-it’s because many common drugs, safe for younger people, become risky for those over 65. That’s where the Beers Criteria comes in. Developed by the American Geriatrics Society (AGS), this living guideline identifies drugs that should be avoided or used with extreme caution in seniors. It’s not a blacklist. It’s a lifeline.

What Exactly Is the Beers Criteria?

The Beers Criteria is a science-backed list of medications that pose higher risks than benefits for adults 65 and older. First created in 1991 by Dr. Mark Beers, it’s been updated every three years since 2011. The latest version, released in May 2023, is based on a review of over 7,300 studies-22% more than the previous update. This isn’t theoretical. It’s practical. It’s used in hospitals, pharmacies, and doctor’s offices across the country.

Why does it matter? Seniors make up just 13.5% of the U.S. population, but they take 34% of all prescription drugs. And about 23% of older adults living at home are on at least one medication flagged by the Beers Criteria. That’s nearly one in four. These drugs contribute to 15% of hospital admissions in this age group-many of which are preventable.

The Five Key Categories of the 2023 Beers Criteria

The 2023 update organizes risky medications into five clear groups. Knowing these helps you understand why a drug might be flagged-not just what it is.

  • Medications to Avoid Altogether-These are drugs with no clear benefit and high risk. Examples include first-generation antihistamines like diphenhydramine (Benadryl) and hydroxyzine. They’re strong anticholinergics, meaning they block a brain chemical needed for memory and focus. In seniors, this can cause confusion, falls, and even long-term cognitive decline. Even short-term use can be dangerous.
  • Drugs to Avoid With Certain Conditions-Some medications are fine for most people but dangerous if you have specific health issues. For instance, NSAIDs like ibuprofen or naproxen can worsen heart failure, cause kidney damage, or trigger bleeding in the stomach. If you have high blood pressure, heart disease, or a history of ulcers, these drugs should be off the table.
  • Drugs to Use With Caution-These aren’t banned, but they need careful monitoring. Dabigatran (Pradaxa), an anticoagulant, increases bleeding risk in people over 75 or those with reduced kidney function. Gabapentin, often prescribed for nerve pain, can cause dizziness and falls if not dosed properly. The key? Dose adjustments based on kidney function, not age.
  • Harmful Drug Interactions-Some drugs are safe alone but deadly together. Combining anticholinergics with opioids or sedatives can lead to severe constipation, urinary retention, or extreme drowsiness. These combos are especially risky for seniors with dementia or mobility issues.
  • Medications Needing Renal Dose Adjustments-Kidneys slow down with age. Many drugs are cleared through the kidneys, so the same dose that’s safe for a 30-year-old can overdose an 80-year-old. Gabapentin, metformin, and many antibiotics require lower doses based on creatinine clearance. Without this adjustment, toxicity builds up silently.

The 2023 list includes 134 medications or classes. Thirty-two new ones were added-like certain antipsychotics for dementia-related agitation-and 18 were removed after new evidence showed they were safer than previously thought.

How It Compares to Other Tools

You might hear about STOPP/START, another guideline used mostly in Europe. The Beers Criteria is more common in the U.S.-used by 87% of healthcare systems compared to 42% for STOPP/START. Why? It’s built for American healthcare. Medicare Part D programs require Beers Criteria checks for seniors on eight or more medications. Most EHR systems, like Epic and Cerner, have Beers alerts built in.

But it’s not perfect. STOPP/START looks at conditions first-like, “Is this drug right for heart failure?”-while Beers focuses on the drug itself. That means sometimes, a flagged drug is actually needed. For example, antipsychotics are listed as inappropriate for dementia-related psychosis. But in rare cases, when agitation leads to violence or self-harm, they may be necessary. That’s why the 2023 update added an Alternatives List-147 evidence-backed options, from cognitive behavioral therapy for insomnia to non-drug pain relief methods.

A pharmacist using a magnifying glass to examine a colorful Beers Criteria chart with animated drug characters in a busy hospital pharmacy.

Real-World Impact: What Happens When It’s Used

When clinics use the Beers Criteria properly, results are clear. One study showed a 28% drop in adverse drug events. Another found that hospitals using EHR alerts reduced inappropriate prescribing by 37% in just six months.

Dr. Lisa Chen, a geriatrician, saw benzodiazepine prescriptions for insomnia drop by 43% in patients over 75 after her clinic added Beers alerts. That’s huge. Benzodiazepines like lorazepam and zolpidem increase fall risk by 50% in seniors. Cutting them saves lives.

But there’s a flip side. One in three primary care doctors say they’re overwhelmed by alerts. One system generates 12 Beers warnings per visit. That’s alert fatigue. When everything blinks red, doctors start ignoring them. The solution? Smart filtering. Prioritize high-risk flags-like anticholinergics in dementia patients-and mute low-risk ones.

Who Uses It-and Who’s Left Out

Pharmacists are the biggest fans. Eighty-nine percent say the Beers Criteria improved their ability to catch dangerous meds during medication reviews. Medicare mandates its use for dual-eligible patients. Pharmaceutical companies are responding: 23 new “senior-friendly” drugs have hit the market since 2023.

But here’s the gap: 61% of seniors don’t even know their meds are being checked against the Beers Criteria. Patients aren’t being told why a drug was changed or why a new one was refused. That erodes trust. And there’s another blind spot: cost. Dr. Jerry Avorn from Harvard points out that 25% of Medicare beneficiaries skip meds because they’re too expensive. The Beers Criteria doesn’t address that. A cheaper, risky drug might be the only option for someone choosing between food and medicine.

An older woman replacing a sedative with non-drug therapies like yoga and light therapy, shown in a hopeful split-scene illustration.

How to Use It Effectively

If you’re a clinician, start with your EHR. Most systems now auto-flag Beers-listed drugs. But don’t rely on alerts alone. Review meds at every visit. Ask: “Why is this still here?” Look for long-term use of anticholinergics, sedatives, or NSAIDs. Check kidney function. Use the free AGS pocket guide or mobile app-downloaded over 87,000 times.

If you’re a caregiver or senior, ask three questions:

  1. Is this drug on the Beers Criteria list?
  2. Is there a safer alternative-drug or non-drug?
  3. What happens if I stop this?

Don’t stop meds on your own. But do bring up the Beers Criteria. Say: “I read about this list. Is my medication on it?” Many doctors will appreciate the conversation.

The Future of Beers: What’s Next

The 2026 update will expand kidney dosing guidance to cover 100% of medications cleared by the kidneys. Right now, only 68% have clear rules. That’s a big step toward precision.

AI is coming. The AGS is working with Google Health to build predictive tools that flag patients at highest risk before they even get prescribed a risky drug. And the Alternatives List will keep growing-adding more non-drug options like exercise for chronic pain, light therapy for depression, and sleep hygiene for insomnia.

Still, challenges remain. In low-resource settings, 63% of Beers-listed drugs have no affordable substitute. That’s a global problem. But in the U.S., the framework is strong. It’s not perfect. But it’s the best tool we have to keep older adults safe, independent, and out of the hospital.

What medications are most commonly flagged by the Beers Criteria?

The top flagged drugs include first-generation antihistamines like diphenhydramine (Benadryl), benzodiazepines like lorazepam and alprazolam, nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and naproxen, antipsychotics such as haloperidol, and certain muscle relaxants like cyclobenzaprine. These are commonly prescribed for insomnia, anxiety, pain, and agitation-but their risks in seniors often outweigh benefits.

Can a medication on the Beers Criteria ever be appropriate?

Yes. The Beers Criteria is a guide, not a rule. For example, antipsychotics are flagged for dementia-related agitation, but if a patient is at risk of harming themselves or others, they may still be necessary. The key is whether the benefit outweighs the risk-and whether alternatives have been tried. The 2023 update’s Alternatives List helps clinicians make those decisions.

How often is the Beers Criteria updated?

The American Geriatrics Society updates the Beers Criteria every three years. The most recent version was published in May 2023. Updates are based on new clinical studies, FDA warnings, and real-world outcomes data. A new update is expected in 2026.

Do Medicare plans require the use of the Beers Criteria?

Yes. Medicare Part D requires prescription drug plans to use the Beers Criteria in medication therapy management programs for dual-eligible beneficiaries-those on both Medicare and Medicaid. This affects over 12 million Americans and ensures that pharmacists review high-risk medications as part of routine care.

Are there free tools available to access the Beers Criteria?

Yes. The American Geriatrics Society offers a free pocket guide and a mobile app that updates quarterly. The app includes the full 2023 list, alternatives, and dosing tips for kidney impairment. It’s been downloaded over 87,000 times and saves clinicians an average of 8.2 minutes per patient encounter.

Written by Zander Fitzroy

Hello, I'm Zander Fitzroy, a dedicated pharmaceutical expert with years of experience in the industry. My passion lies in researching and developing innovative medications that can improve the lives of patients. I enjoy writing about various medications, diseases, and the latest advancements in pharmaceuticals. My goal is to educate and inform the public about the importance of pharmaceuticals and how they can impact our health and well-being. Through my writing, I strive to bridge the gap between science and everyday life, demystifying complex topics for my readers.

Martin Halpin

Look, I get that the Beers Criteria is supposed to be this holy grail for geriatric meds, but let’s be real - it’s just another bureaucratic checklist that turns doctors into compliance robots. I’ve seen a 79-year-old with chronic pain get yanked off naproxen because it’s on the list, then prescribed this $400/month ‘safer’ alternative that her Medicare won’t cover. So now she’s hobbling around in agony while the algorithm says ‘all good.’ The real issue isn’t the drugs - it’s that we’ve outsourced clinical judgment to a spreadsheet. And don’t even get me started on how these ‘alternatives’ are just ‘try yoga’ or ‘take a walk’ like we’re all living in a Whole Foods with a personal trainer.

It’s not about avoiding risk - it’s about managing it. And sometimes, that means letting a patient take a little risk so they can actually enjoy their last years without being drugged into a zombie state. The Beers list? It’s a safety net. But when it becomes a cage? That’s when the real harm happens.

Eimear Gilroy

Interesting breakdown - especially the part about kidney dosing. I work in a community pharmacy and see this daily. A lot of older patients are on gabapentin for neuropathy, and no one checks their creatinine clearance. One lady was on 300mg TID for years - her kidney function was at 32 mL/min. We switched her to 100mg once daily and her dizziness vanished. No one had ever asked about her renal function before. It’s not that the drugs are bad - it’s that we stop thinking about the person behind the prescription.

Also, the Alternatives List is a game-changer. I had a patient on melatonin and zolpidem for insomnia for a decade. We tried light therapy and sleep hygiene. She’s now off both, sleeping better, and doesn’t wake up feeling like she got hit by a truck. Small changes, huge impact.

Joseph Cantu

They’re lying to you. The Beers Criteria? It’s not about safety - it’s about cost-cutting disguised as science. Big Pharma doesn’t want you on cheap generics like diphenhydramine - they want you on their $200/month ‘senior-friendly’ version. The FDA, AGS, and Medicare? All in bed together. They push this list so hospitals can avoid liability and insurers can deny claims. You think they care if your grandma’s sleep improves? No. They care if they get sued because she fell. So they ban everything. Then they sell you the ‘safe’ version that’s just the same drug with a fancy label and a higher price tag.

And don’t get me started on the ‘alternatives.’ Yoga? Light therapy? That’s what they give you when they don’t have the money to pay for real medicine. It’s a scam. And they call it ‘evidence-based.’ Bullshit. It’s profit-based.

David McKie

Let’s not pretend this is about patient care. It’s about liability. Every time a doctor prescribes something on the Beers list, they’re playing Russian roulette with a malpractice lawsuit. So they default to the algorithm - even if it makes no clinical sense. I’ve seen patients with severe arthritis get pulled off NSAIDs and put on acetaminophen - which doesn’t work - because the EHR screamed ‘DANGER.’ Then they end up in the ER because their pain got worse and they took too much Tylenol. Toxicity isn’t just from the flagged drugs - it’s from the *replacement* ones.

And the ‘alert fatigue’? That’s not a bug - it’s a feature. The system is designed to overwhelm you so you stop thinking. You don’t question the list. You just click ‘accept.’ That’s how you lose clinical autonomy. And it’s not just doctors - pharmacists are now trained to be enforcers, not caregivers. This isn’t medicine. It’s risk management dressed in white coats.

Southern Indiana Paleontology Institute

Y’all are overthinking this. Benadryl? Bad for old folks? Yeah. So don’t give it to em. Simple. NSAIDs? Can wreck kidneys? Then don’t give em to folks with high BP. Done.

But we keep makin’ this into some big government conspiracy. It’s not. It’s just common sense. If your grandpa’s 80 and his kidneys are slow, you don’t give him the same dose as a 25-year-old. Duh. Why do we need a 70-page list for that? We don’t. We need doctors who know how to think. Not apps. Not alerts. Just good ol’ clinical judgment.

And yeah, some of the ‘alternatives’ are dumb. But that’s not the list’s fault. That’s the docs’ fault for not explaining. We got a whole generation of old people who think their meds are magic. They ain’t. They’re tools. Use em right or don’t use em at all.

Anil bhardwaj

As someone from India, I find this fascinating. In our rural clinics, we don’t have EHR alerts or Beers lists. We just use what’s cheap and available. So yes, we give diphenhydramine for sleep, ibuprofen for pain, and cyclobenzaprine for back spasms - even to 80-year-olds. And honestly? Most of them are fine. Maybe because they’re more active, eat less processed food, and don’t take 10 pills a day.

Maybe the problem isn’t the drugs - it’s polypharmacy. In the U.S., people are on 8+ meds because every specialist wants to fix one thing. But nobody’s looking at the whole picture. Here, we just give one thing. And if it works? Good. If not? We try something else. Maybe we need fewer lists and more holistic care.

lela izzani

I’m a geriatric nurse practitioner and I can’t tell you how many times I’ve seen families come in panicked because their parent’s doctor ‘took away’ their Benadryl. They think it’s being withheld like a punishment. But once we explain - ‘This isn’t about taking away comfort - it’s about preventing confusion, falls, and long-term brain changes’ - they get it.

One of my patients, 82, was on lorazepam for anxiety and diphenhydramine for allergies. She was falling weekly. We switched to a non-sedating antihistamine, started cognitive behavioral therapy for anxiety, and added a home safety eval. Six months later, she’s hiking with her grandkids. No meds. Just better care.

The Beers Criteria isn’t perfect, but it’s the best tool we have to stop treating seniors like broken machines we keep patching. It’s about dignity. And sometimes, that means saying no - even when it’s hard.

Joanna Reyes

I’ve been reading up on this for months now, mostly because my mom was on three Beers-listed meds for years - gabapentin for ‘nerve pain,’ melatonin for sleep, and a muscle relaxant for back spasms. No one ever questioned it. She was on them since 2018. I found the AGS app, looked up each one, and printed out the alternatives. Took it to her PCP. He was surprised I’d done the research.

Turns out, her ‘nerve pain’ was just arthritis. Her ‘sleep issues’ were from caffeine and lack of sunlight. The muscle relaxant? Just made her dizzy. We tapered everything off, started physical therapy, got her a light therapy lamp, and now she’s sleeping 7 hours straight, walks without a cane, and hasn’t had a fall in 11 months.

It’s not that the drugs are evil. It’s that we stop asking why they’re still there. The Beers Criteria doesn’t tell you to stop - it tells you to question. And that’s the most powerful thing it does. I wish more people knew that.

Stephen Archbold

Just wanted to say - this post was super helpful. I’m a caregiver for my dad (79) and I had no idea any of this stuff existed. I thought doctors just knew what they were doin’. Turns out they’re just as overwhelmed as we are.

Found the AGS app on my phone. Put in his meds. Three hits. Benadryl, gabapentin, and naproxen. I didn’t panic. Just asked his pharmacist. She said, ‘Good on ya for checking.’ We switched the Benadryl to a non-drowsy one, cut the gabapentin in half, and swapped naproxen for topical diclofenac. No more falls. Better sleep. And he’s not mad at me for ‘taking his meds.’

Big thanks. I didn’t know I could ask questions like this. Turns out, I can. And I should. 😊